| NCT ID | NCT06874556 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 75 participants |
| Start Date | 2025-06-24 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 75 participants in total. It began in 2025-06-24 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research is to see if having community paramedic (CP) visit patients at home to manage their heart failure help them stay out of the hospital and improve their overall health compared to standard care. The investigators want to find out if their approach is better for patients in terms of their quality of life, hospital stays, emergency visits, and cost. The investigators are also looking to see how happy patients and doctors are with this method and if it's a practical and sustainable option for the future.
Eligibility Criteria
Inclusion Criteria: One of the following criteria: 1. Adults admitted to the hospital with decompensated HF eligible for early discharge with CP support and monitoring. 2. Acutely decompensated HF patients at home or being evaluated in the ambulatory clinic who require large volume diuresis but do not require hospital-level monitoring. 3. Stage D advanced HF patients who require frequent (\>weekly) diuretic adjustments (either inpatient or outpatients). Exclusion Criteria: 1. Hospital-level monitoring or care is clinically indicated. 2. Failed safety assessment, active substance abuse, or behavioral health diagnosis which could impact participation. 3. Enrolled in hospice. 4. Patient is a resident in a skilled nursing facility. 5. Patient does not have a primary care physician or cardiologist at Mayo Clinic. 6. Patient participants with communication barriers due to medical illness or cognitive impairment. 7. Pregnant
Contact & Investigator
Sara Severson, APRN, C.N.P.
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT06874556 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06874556 currently recruiting?
Yes, NCT06874556 is actively recruiting participants. Contact the research team at Biorn.Sara@mayo.edu for enrollment information.
Where is the NCT06874556 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT06874556 clinical trial?
NCT06874556 is sponsored by Mayo Clinic. The principal investigator is Sara Severson, APRN, C.N.P. at Mayo Clinic. The trial plans to enroll 75 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.